Our Core Vision

“A Bangladesh free from preventable liver cancer, where every individual—regardless of geographic or economic barrier—has access to timely diagnosis, world-class multidisciplinary treatment, and compassionate clinical care.”

The Vision in Action

1. Nationwide Elimination of Preventable Liver Cancer

  • Establishing widespread immunity through universal Hepatitis B vaccination and sustained public health education.

  • Eradicating viral hepatitis transmission and halting the progression of metabolic dysfunction-associated steatotic liver disease (fatty liver) across urban and rural populations.

2. Early Detection as a Universal Standard

  • Transitioning clinical outcomes from late-stage palliation to early-stage curative intervention.

  • Decentralizing liver surveillance so high-risk patients (those with cirrhosis, chronic HBV, or chronic HCV) across all 64 districts undergo routine, standardized ultrasound and biomarker screening.

3. Regional Hub for Hepatobiliary Excellence

  • Building a self-reliant medical ecosystem in Bangladesh where patients no longer need to travel abroad for advanced liver care.

  • Expanding domestic capacity for liver transplantation, complex anatomical resections, interventional radiology (TACE, RFA, MWA), and next-generation targeted therapies.

4. Indigenous Research & Clinical Leadership

  • Leading high-impact epidemiological and genetic research to map liver disease etiology unique to the South Asian population.

  • Shaping national health policies and contributing authoritative guidelines to the global oncological community.

Strategic Roadmap Toward Our Vision

Horizon Milestone Focus
Near-Term Expand physician CME programs, publish standardized national screening guidelines, and broaden community screening camps.
Mid-Term Establish a unified national liver tumor board network and integrate routine liver cancer surveillance into regional tertiary hospitals.
Long-Term Foster high-volume, accessible liver transplantation centers and spearhead indigenous clinical research trials across Bangladesh.